Consonance Capital Management LP 13D and 13G filings for OXFORD IMMUNOTEC GLOBAL PLC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-17 3:14 pm Sale | 2020-12-31 | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD | Consonance Capital Management LP | 0 0.000% | -6,058,505 (Position Closed) | Filing |
| 2021-02-16 4:19 pm Purchase | 2020-12-31 | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD | Consonance Capital Management LP | 6,058,505 11.000% | 6,058,505 (New Position) | Filing |
| 2021-02-16 2:39 pm Sale | 2020-12-31 | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD | Consonance Capital Management LP | 0 0.000% | -2,363,724 (Position Closed) | Filing |
| 2020-02-14 3:40 pm Sale | 2019-12-31 | 13G | OXFORD IMMUNOTEC GLOBAL PLC OXFD | Consonance Capital Management LP | 2,363,724 8.940% | -216,060 (-8.38%) | Filing |